Skip to main content
Year archive

Y-Biologics, Inc — 2023 filings

All 28 regulatory filings released by Y-Biologics, Inc (338840) in 2023, sourced directly from the official regulator.

28 Filings
2023 Period
2023 filings (28)
Filing Released Lang
[기재정정]기타경영사항(자율공시)(전환우선주의 보통주 전환청구)
Share Issue/Capital Change
2023-12-26 Korean
[기재정정]기타경영사항(자율공시)(전환우선주의 보통주 전환청구)
Share Issue/Capital Change
2023-12-26 Korean
[기재정정]기타경영사항(자율공시)(전환우선주의 보통주 전환청구)
Share Issue/Capital Change
2023-12-22 Korean
[기재정정]기타경영사항(자율공시)(전환우선주의 보통주 전환청구)
Share Issue/Capital Change
2023-12-19 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-12-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-12-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-12-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-12-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-12-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-12-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-12-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-12-13 Korean
기타경영사항(자율공시)(전환우선주의 보통주 전환청구)
Share Issue/Capital Change
2023-12-07 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2023-12-06 Korean
증권발행실적보고서
Share Issue/Capital Change
2023-11-28 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change
2023-11-21 Korean
[기재정정]투자설명서
Capital/Financing Update
2023-11-21 Korean
[기재정정]분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-16 Korean
[기재정정]분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-15 Korean
투자설명서
Capital/Financing Update
2023-11-14 Korean
[기재정정]증권신고서(지분증권)
Capital/Financing Update
2023-11-03 Korean
[기재정정]증권신고서(지분증권)
Share Issue/Capital Change
2023-10-23 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-10-20 Korean
증권신고서(지분증권)
Share Issue/Capital Change
2023-10-05 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-14 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-12 Korean
사업보고서 (2022.12)
Audit Report / Information FY 2022
2023-04-14 Korean
감사보고서 (2022.12)
Audit Report / Information FY 2022
2023-03-22 Korean